Anti-BACE2 antibody [1/9]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Mouse Recombinant Monoclonal BACE2 antibody. Suitable for ICC, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human BACE2 aa 200-350.
View Alternative Names
AEPLC, ALP56, ASP21, CDA13, UNQ418/PRO852, BACE2, Beta-secretase 2, Aspartic-like protease 56 kDa, Aspartyl protease 1, Beta-site amyloid precursor protein cleaving enzyme 2, Down region aspartic protease, Memapsin-1, Membrane-associated aspartic protease 1, Theta-secretase, ASP1, Asp 1, Beta-site APP cleaving enzyme 2, DRAP
- ICC
Supplier Data
Immunocytochemistry - Anti-BACE2 antibody [1/9] (AB245679)
PFA fixed, 0.15% Triton permeabilized U-251 MG (Human brain glioma cell line) cells labeling BACE2 using ab245679 at 10 μg/ml for 1 hour (green) followed by Alexa Fluor® 488 secondary antibody (2 μg/ml), in ICC/IF. The nuclear counter stain is DAPI (blue0.
- WB
Supplier Data
Western blot - Anti-BACE2 antibody [1/9] (AB245679)
10% SDS PAGE gel.
Detected by chemiluminescence.
All lanes:
Western blot - Anti-BACE2 antibody [1/9] (ab245679) at 1 µg/mL
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate (protein in RIPA buffer) at 35 µg
Lane 2:
U-251 MG (Human brain glioma cell line) cell lysate (protein in RIPA buffer) at 35 µg
Predicted band size: 56 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BACE2 acts on substrates to regulate amyloidogenic processing of APP. It belongs to the peptidase A1 Family. Unlike its counterpart BACE1 which promotes amyloid-beta peptide production BACE2 has been suggested to reduce amyloid-beta formation by different substrate cleavage. Though not part of a stable complex BACE2 influences pathways related to protein processing.
Pathways
One should note that BACE2 is involved in the amyloidogenic pathway. This pathway processes APP and affects amyloid-beta levels important in neurological conditions. BACE2 acts with proteins like APP and might modulate the effects seen due to BACE1 activity. Despite overlapping functions BACE2 and BACE1 have distinct roles in this pathway impacting amyloid levels differently.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com